Total Payments
$7,110
2024 Payments
$920.31
Companies
28
Transactions
398
Medicare Patients
15,861
Medicare Billing
$999,118
Payment Breakdown by Category
Food & Beverage$6,804 (95.7%)
Education$190.81 (2.7%)
Other$115.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,804 | 392 | 95.7% |
| Education | $190.81 | 5 | 2.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $115.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,073 | 38 | $0 (2024) |
| Boston Scientific Corporation | $1,023 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $816.53 | 77 | $0 (2024) |
| Amgen Inc. | $695.39 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $351.56 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $347.46 | 19 | $0 (2019) |
| Gilead Sciences, Inc. | $340.58 | 33 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $314.39 | 9 | $0 (2024) |
| PFIZER INC. | $291.31 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $280.01 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $920.31 | 34 | AstraZeneca Pharmaceuticals LP ($287.21) |
| 2023 | $613.85 | 17 | Boston Scientific Corporation ($231.50) |
| 2022 | $497.16 | 16 | AstraZeneca Pharmaceuticals LP ($153.62) |
| 2021 | $344.91 | 8 | AstraZeneca Pharmaceuticals LP ($186.03) |
| 2020 | $11.28 | 1 | Amgen Inc. ($11.28) |
| 2019 | $1,472 | 112 | Amgen Inc. ($247.02) |
| 2018 | $1,681 | 99 | BOSTON SCIENTIFIC CORPORATION ($350.04) |
| 2017 | $1,569 | 111 | Gilead Sciences Inc ($194.17) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Terumo Medical Corporation | GLIDESHEATH SLENDER (Device), ANGIO-SEAL | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: LESION ACCESS | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Cardiovascular | ||||||
| 06/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $92.28 | General |
| Category: Cardiology | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $142.08 | General |
| 05/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology | ||||||
| 04/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $103.05 | General |
| Category: Cardiovascular | ||||||
| 04/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Cardiovascular | ||||||
| 04/08/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $102.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: DIABETES | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,697 | 5,680 | $491,769 | $218,237 |
| 2022 | 29 | 3,630 | 5,566 | $530,803 | $241,746 |
| 2021 | 30 | 3,927 | 5,738 | $1.0M | $277,484 |
| 2020 | 35 | 4,607 | 6,346 | $1.1M | $261,652 |
Total Patients
15,861
Total Services
23,330
Medicare Billing
$999,118
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 847 | 1,572 | $232,656 | $101,055 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 362 | $53,576 | $22,482 | 42.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 83 | 83 | $36,935 | $16,940 | 45.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 180 | 180 | $20,700 | $9,443 | 45.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 20 | $17,880 | $8,882 | 49.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 984 | 1,631 | $19,572 | $7,983 | 40.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 147 | 147 | $15,288 | $7,051 | 46.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 73 | 237 | $10,665 | $5,210 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 53 | 53 | $10,706 | $5,025 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 94 | $9,448 | $3,562 | 37.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 49 | $5,194 | $2,951 | 56.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 182 | 182 | $5,824 | $2,723 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 66 | 68 | $6,800 | $2,662 | 39.2% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $5,792 | $2,656 | 45.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $5,200 | $2,631 | 50.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 29 | 29 | $4,669 | $2,380 | 51.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 13 | 108 | $4,320 | $2,157 | 49.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 24 | 75 | $4,200 | $2,096 | 49.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 246 | 370 | $4,440 | $1,892 | 42.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 182 | 182 | $4,004 | $1,845 | 46.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,835 | $1,736 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,232 | $1,552 | 48.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 14 | $2,268 | $1,112 | 49.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 14 | $798.00 | $542.08 | 67.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 27 | 36 | $1,116 | $481.32 | 43.1% |
About Dr. Mehran Arabpour, DO
Dr. Mehran Arabpour, DO is a Cardiovascular Disease healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457314478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mehran Arabpour, DO has received a total of $7,110 in payments from pharmaceutical and medical device companies, with $920.31 received in 2024. These payments were reported across 398 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,804).
As a Medicare-enrolled provider, Arabpour has provided services to 15,861 Medicare beneficiaries, totaling 23,330 services with total Medicare billing of $999,118. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lima, OH
- Active Since 04/10/2006
- Last Updated 12/29/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1457314478
Products in Payments
- XARELTO (Drug) $816.53
- Repatha (Biological) $422.72
- FARXIGA (Drug) $378.41
- ELIQUIS (Drug) $361.68
- ENTRESTO (Drug) $304.84
- BRILINTA (Drug) $276.37
- Corlanor (Drug) $272.67
- Impella (Device) $222.45
- UPTRAVI (Drug) $191.05
- WAINUA (Drug) $190.48
- GENERAL THERAPIES (Device) $190.29
- MULTAQ (Drug) $179.08
- PRALUENT (Drug) $168.38
- Livalo (Drug) $160.13
- Vascepa (Drug) $146.91
- WATCHMAN Access System (Device) $144.03
- NORTHERA (Drug) $142.47
- LifeVest (Device) $132.92
- CARDIOMEMS (Device) $128.80
- CAMZYOS (Drug) $124.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lima
Dr. Pamela Gardner, Do, DO
Cardiovascular Disease — Payments: $24,123
Cardiovascular Disease $24,123
Masroor Abro, M.d, M.D
Cardiovascular Disease — Payments: $14,304
Cardiovascular Disease $14,304
Dr. Paul Anike, Do, DO
Cardiovascular Disease — Payments: $12,788
Cardiovascular Disease $12,788
Dr. Venkat Battula, Md, MD
Cardiovascular Disease — Payments: $11,418
Cardiovascular Disease $11,418
Adel Shaheen, Md, MD
Cardiovascular Disease — Payments: $8,259
Cardiovascular Disease $8,259
Julius Kato, Do, DO
Cardiovascular Disease — Payments: $6,058
Cardiovascular Disease $6,058